Weighted-Average Shares Outstanding (Diluted): The number of shares held by shareholders including insiders but not including a company's treasury shares assuming conversion of all convertible debt, securities, warrants and options, sourced from the company 10-K or 10-Q SEC reports.
Brainstorm Cell Therapeutics Inc. (BCLI) had Weighted-Average Shares Outstanding (Diluted) of 11.01M for the most recently reported fiscal quarter, ending 2025-09-30.
| Income Statement Financials | |
-- |
|
$-2.11M |
|
-- |
|
-- |
|
$2.05M |
|
$-2.05M |
|
$-0.06M |
|
$-2.11M |
|
$-2.11M |
|
$-2.11M |
|
$-2.11M |
|
$-2.11M |
|
$-2.11M |
|
$-2.05M |
|
$-2.00M |
|
11.01M |
|
|
Weighted-Average Shares Outstanding (Diluted) |
11.01M |
$-0.19 |
|
$-0.19 |
|
| Balance Sheet Financials | |
$0.51M |
|
$0.28M |
|
$0.87M |
|
$1.38M |
|
$9.02M |
|
-- |
|
$0.05M |
|
$9.07M |
|
$-7.69M |
|
$-7.69M |
|
$-7.69M |
|
11.04M |
|
| Cash Flow Statement Financials | |
$-6.24M |
|
$0.00M |
|
$6.10M |
|
$0.37M |
|
$0.24M |
|
$-0.14M |
|
$1.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.06 |
|
-- |
|
-- |
|
-- |
|
-0.01 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-6.24M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
27.38% |
|
27.38% |
|
-152.61% |
|
27.38% |
|
$-0.70 |
|
$-0.57 |
|
$-0.57 |
|